PetIQ, Inc. (PETQ)

USD 30.98

(-0.03%)

Operating Income Summary of PetIQ, Inc.

  • PetIQ, Inc.'s latest annual operating income in 2023 was 60.01 Million USD , up 120.38% from previous year.
  • PetIQ, Inc.'s latest quarterly operating income in 2024 Q2 was 28.97 Million USD , up 16.65% from previous quarter.
  • PetIQ, Inc. reported an annual operating income of 27.23 Million USD in 2022, up 71.57% from previous year.
  • PetIQ, Inc. reported an annual operating income of 15.87 Million USD in 2021, up 706.73% from previous year.
  • PetIQ, Inc. reported a quarterly operating income of 28.97 Million USD for 2024 Q2, up 16.65% from previous quarter.
  • PetIQ, Inc. reported a quarterly operating income of 9.35 Million USD for 2023 Q3, down -50.03% from previous quarter.

Annual Operating Income Chart of PetIQ, Inc. (2023 - 2014)

Historical Annual Operating Income of PetIQ, Inc. (2023 - 2014)

Year Operating Income Operating Income Growth
2023 60.01 Million USD 120.38%
2022 27.23 Million USD 71.57%
2021 15.87 Million USD 706.73%
2020 -2.61 Million USD -160.07%
2019 4.35 Million USD -43.79%
2018 7.74 Million USD -41.7%
2017 13.28 Million USD 1793.02%
2016 702 Thousand USD -80.34%
2015 3.57 Million USD 143.25%
2014 -8.25 Million USD 0.0%

Peer Operating Income Comparison of PetIQ, Inc.

Name Operating Income Operating Income Difference
Esperion Therapeutics, Inc. -155.56 Million USD 138.579%
Theratechnologies Inc. -10.62 Million USD 664.741%
Safety Shot Inc -12.18 Million USD 592.566%
Cosmos Health Inc. -21.83 Million USD 374.905%
Cronos Group Inc. -81.37 Million USD 173.751%
Ironwood Pharmaceuticals, Inc. 209.03 Million USD 71.29%
Kala Pharmaceuticals, Inc. -39.15 Million USD 253.283%
Organogenesis Holdings Inc. 12.52 Million USD -379.162%
Universe Pharmaceuticals INC -3.52 Million USD 1801.697%
ProPhase Labs, Inc. -21.61 Million USD 377.68%
Sonoma Pharmaceuticals, Inc. -4.7 Million USD 1376.643%
Dynavax Technologies Corporation -37.02 Million USD 262.08%
Radius Health, Inc. -3.92 Million USD 1629.045%
China SXT Pharmaceuticals, Inc. -2.51 Million USD 2486.076%
Alvotech -354.86 Million USD 116.912%
Sunshine Biopharma, Inc. -4.78 Million USD 1354.154%
Alpha Teknova, Inc. -35.56 Million USD 268.757%
Intra-Cellular Therapies, Inc. -159.38 Million USD 137.655%
SCYNEXIS, Inc. 72.66 Million USD 17.413%
Harrow Health, Inc. 580 Thousand USD -10247.414%
Biofrontera Inc. -22.67 Million USD 364.651%
DURECT Corporation -36.88 Million USD 262.713%
Supernus Pharmaceuticals, Inc. -5.26 Million USD 1239.021%
ANI Pharmaceuticals, Inc. 46.97 Million USD -27.77%
OptiNose, Inc. -22.74 Million USD 363.825%
RedHill Biopharma Ltd. 12.63 Million USD -375.103%
Aquestive Therapeutics, Inc. -15.1 Million USD 497.398%
Cumberland Pharmaceuticals Inc. -6.21 Million USD 1066.298%
SIGA Technologies, Inc. 83.62 Million USD 28.23%
Lifecore Biomedical, Inc. 9.33 Million USD -543.179%
Shineco, Inc. -17.06 Million USD 451.667%
Phibro Animal Health Corporation 53.31 Million USD -12.567%
Procaps Group S.A. 52.32 Million USD -14.699%
TherapeuticsMD, Inc. -8.52 Million USD 804.153%
Regencell Bioscience Holdings Limited -4.73 Million USD 1367.014%
Viatris Inc. 766.2 Million USD 92.167%
Sunshine Biopharma, Inc. -4.78 Million USD 1354.154%
Rockwell Medical, Inc. -6.67 Million USD 999.775%
Incannex Healthcare Limited -30.04 Million USD 299.777%
Aytu BioPharma, Inc. -5.25 Million USD 1242.273%
Tilray Brands, Inc. -174.74 Million USD 134.344%
Collegium Pharmaceutical, Inc. 166.96 Million USD 64.054%
Silver Spike Investment Corp. 7.34 Million USD -717.631%
Neurocrine Biosciences, Inc. 250.9 Million USD 76.08%
Journey Medical Corporation -2.07 Million USD 2995.08%
Alimera Sciences, Inc. -1.47 Million USD 4179.878%
Petros Pharmaceuticals, Inc. -13.61 Million USD 540.724%
Assertio Holdings, Inc. -243.53 Million USD 124.643%
Shuttle Pharmaceuticals Holdings, Inc. -5.89 Million USD 1118.519%
Embecta Corp. 221.5 Million USD 72.905%
Cyclo Therapeutics, Inc. -20.05 Million USD 399.326%
Procaps Group, S.A. 38.97 Million USD -53.991%
PainReform Ltd. -9.58 Million USD 726.2%
Avadel Pharmaceuticals plc -137.84 Million USD 143.537%
Hempacco Co., Inc. -8.81 Million USD 781.038%
Talphera, Inc. -16.88 Million USD 455.35%
Pacira BioSciences, Inc. 87.67 Million USD 31.548%
Alvotech -354.86 Million USD 116.912%
Lantheus Holdings, Inc. 364.64 Million USD 83.541%
Kamada Ltd. 10.06 Million USD -496.333%
Indivior PLC -4 Million USD 1600.375%
Currenc Group, Inc. -6.64 Million USD 1003.054%
Evoke Pharma, Inc. -7.43 Million USD 907.642%
Flora Growth Corp. -50.35 Million USD 219.186%
Cyclo Therapeutics, Inc. -20.05 Million USD 399.326%
Evolus, Inc. -49.23 Million USD 221.9%
HUTCHMED (China) Limited 18.37 Million USD -226.612%
Amphastar Pharmaceuticals, Inc. 196.98 Million USD 69.534%
Akanda Corp. -10.05 Million USD 697.083%